This proposed rule focuses totally on PMTA assessment treatments and content material specifications, specially with respect to software acceptance and filing. An application may well fulfill the acceptance and submitting requirements, but nonetheless deficiency vital details that FDA wants to determine regardless of whether it need to challenge a